424 related articles for article (PubMed ID: 9222707)
1. Effect of gastric mucosal protection in nonrheumatoid patients with short-term nonsteroidal anti-inflammatory drug therapy: a prospective randomized multicenter study.
Miller K
Hepatogastroenterology; 1997; 44(15):872-9. PubMed ID: 9222707
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
[TBL] [Abstract][Full Text] [Related]
3. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
Miglioli M; Bianchi Porro G; Vaira D; Menegatti M; Brunetti G; Petrillo M; Ardizzone S; Frizziero L; Montrone F; Grandinetti G
Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419
[TBL] [Abstract][Full Text] [Related]
4. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
5. [Nonvariceal upper gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drugs in Metropolitan Lima].
Salvatierra Laytén G; de la Cruz Romero L; Paulino Merino M; Vidal Vidal V; Rivera Dávila C; Cano Chuquilin A; Frisancho Velarde O
Rev Gastroenterol Peru; 2006; 26(1):13-20. PubMed ID: 16622483
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
Koch M
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
[TBL] [Abstract][Full Text] [Related]
7. Variations in the risk of gastrointestinal hemorrhage with non-steroidal anti-inflammatory drugs and localization of lesions.
Pulanić R; Dubravcić D; Ostojić-Pulanić B; Vrhovac B
Acta Med Croatica; 1998; 52(2):91-8. PubMed ID: 9682495
[TBL] [Abstract][Full Text] [Related]
8. Sucralfate therapy in NSAID bleeding gastropathy.
Malagelada JR; Rodríguez de la Serna A; Dammann HG; Pons M; Armas C; Sala M; Tena X; Celdrán E; Mesa A
Clin Gastroenterol Hepatol; 2003 Jan; 1(1):51-6. PubMed ID: 15017517
[TBL] [Abstract][Full Text] [Related]
9. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.
Wilcox CM; Shalek KA; Cotsonis G
Arch Intern Med; 1994 Jan; 154(1):42-6. PubMed ID: 8267488
[TBL] [Abstract][Full Text] [Related]
10. Interactions between anti-ulcer drugs and non-steroidal anti-inflammatory drugs in cirrhotic patients with bleeding esophagogastric varices.
Yoshida H; Mamada Y; Taniai N; Mineta S; Kawano Y; Mizuguchi Y; Kakinuma D; Kanda T; Tajiri T
Hepatogastroenterology; 2009; 56(94-95):1366-70. PubMed ID: 19950793
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
12. NSAID-induced gastric mucosal damage.
Semble EL; Wu WC
Am Fam Physician; 1987 Jun; 35(6):101-8. PubMed ID: 3332745
[TBL] [Abstract][Full Text] [Related]
13. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor.
Goldstein JL; Silverstein FE; Agrawal NM; Hubbard RC; Kaiser J; Maurath CJ; Verburg KM; Geis GS
Am J Gastroenterol; 2000 Jul; 95(7):1681-90. PubMed ID: 10925968
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial.
Simon LS; Hatoum HT; Bittman RM; Archambault WT; Polisson RP
Fam Med; 1996 Mar; 28(3):204-10. PubMed ID: 8900554
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal lesions during treatment with non-steroidal anti-inflammatory drugs (NSAIDs).
Festen HP
Neth J Med; 1989 Dec; 35(5-6):327-33. PubMed ID: 2699655
[TBL] [Abstract][Full Text] [Related]
16. Gastroduodenal complications of chronic NSAID therapy.
Graham DY; Smith JL
Am J Gastroenterol; 1988 Oct; 83(10):1081-4. PubMed ID: 3048080
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfate.
Lazzaroni M; Sainaghi M; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S48-53. PubMed ID: 10379470
[TBL] [Abstract][Full Text] [Related]
18. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
Russell RI
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
[TBL] [Abstract][Full Text] [Related]
19. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
